文献速递瓣膜病与结构性心脏病

升主动脉直径与单纯主动脉瓣反流经导管主动脉瓣置换术:NTCVR注册研究

Ascending aorta and pure aortic regurgitation transcatheter aortic valve replacement: insights from the National Transcatheter Valve Therapeutics Registry.
PubMed 文献 · Heart · 2026-08-07

基于中国NTCVR数据库2017–2023年72中心890例单纯主动脉瓣反流患者,行自膨胀经股动脉TAVR,院内和30天全因死亡率分别为2.0%和2.7%。多因素回归和机器学习均提示升主动脉直径是30天全因死亡的关键预测因素,升主动脉>41.6 mm者30天全因死亡率显著更高(OR 5.027)。

要点

  • 升主动脉直径是单纯AR患者自膨胀TF-TAVR后30天全因死亡的关键预测因素。
  • 升主动脉>41.6 mm者30天全因死亡率显著升高(OR 5.027)。
  • 肾功能不全是30天全因死亡的独立危险因素(OR 4.602)。

核心结论

  • 升主动脉直径是单纯主动脉瓣反流患者行自膨胀经股动脉TAVR后30天全因死亡的关键预测因素。
  • 升主动脉直径>41.6 mm的患者30天全因死亡率显著更高(OR 5.027,95%CI 2.042–12.696,p=0.0004)。

研究设计与样本

  • 基于中国NTCVR数据库的多中心、回顾性队列研究,纳入2017年1月至2023年12月72个中心的890例单纯主动脉瓣反流患者(平均年龄73.2岁,男性56.3%)。
  • 主要终点为30天全因死亡,采用逻辑回归和机器学习(XGBoost联合SHAP分析)识别危险因素。

主要发现

  • 院内全因死亡率为2.0%,30天全因死亡率为2.7%。
  • 多因素逻辑回归显示升主动脉直径(OR 1.103,95%CI 1.005–1.212,p=0.039)和肾功能不全(OR 4.602,95%CI 1.455–14.553,p=0.009)与30天全因死亡相关。
  • 机器学习SHAP分析同样将升主动脉直径列为关键预测因素;升主动脉>41.6 mm者30天全因死亡OR为5.027(95%CI 2.042–12.696,p=0.0004)。
  • 多因素分析中NYHA III/IV级和瓣环长径是技术成功的预测因素。

关键数值与推荐

  • 升主动脉直径>41.6 mm作为30天全因死亡风险增高的参考阈值(OR 5.027,95%CI 2.042–12.696,p=0.0004)。

临床怎么用

  • 对拟行自膨胀TF-TAVR的单纯主动脉瓣反流患者,应评估升主动脉直径,>41.6 mm者提示30天全因死亡风险显著增高。
  • 合并肾功能不全者风险亦增高,需综合评估并加强围术期管理。

局限性

  • 本研究为注册登记为基础的观察性、探索性研究,可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data regarding the association between self-expandable transfemoral transcatheter aortic valve replacement (TF-TAVR) and pure native aortic regurgitation (PNAR) are limited. The authors described their initial experience with self-expandable TF-TAVR for the treatment of patients with PNAR from the NTCVR database in China. METHODS: This was a national registry-based, multicentre, retrospective cohort study. Patients with PNAR were enrolled from the NTCVR in China between January 2017 and December 2023. The primary endpoint event was all-cause mortality at 30 days. Logistic regression analysis and machine learning techniques were used to identify the risk factors associated with 30-day all-cause mortality of TF-TAVR in patients with PNAR. RESULTS: Total 890 patients with PNAR (mean age 73.2 years; 56.3% men) from 72 centres in China were enrolled in this study. The in-hospital and 30-day all-cause mortality were 2.0% and 2.7%, respectively. By multivariate logistic regression analysis, the diameter of the ascending aorta (OR, 1.103 (95% CI 1.005 to 1.212); p=0.039) and renal insufficiency (OR, 4.602 (95% CI 1.455 to 14.553); p=0.009) were associated with the 30-day all-cause mortality. Moreover, Shapley Additive explanations analysis for the machine learning model XGBoost also highlighted the diameter of the ascending aorta as the key predictor; patients with an ascending aorta greater than 41.6 mm had a significantly higher 30-day all-cause mortality rate (OR, 5.027 (95% CI 2.042 to 12.696); p=0.0004). Moreover, the NYHA class III/IV and annulus long diameter were predictors of technical success in multivariate analysis. CONCLUSION: In this large national registry-based observational and exploratory study, we identified the ascending aorta as the key predictor for PNAR patients who underwent self-expandable TF-TAVR. Patients with ascending aortic diameters greater than 41.6 mm may have a significantly higher 30-day all-cause mortality rate.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Hong N, Chen L, Liu XB, et al. Ascending aorta and pure aortic regurgitation transcatheter aortic valve replacement: insights from the National Transcatheter Valve Therapeutics Registry. Heart. 2026. PMID: 42567693. doi:10.1136/heartjnl-2025-327742

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。